Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vivi1003g00002 | ATGGGCGATCTTGAAAGAATGGGCAGAGAACTCAAATGTCCAATCTGTTGGAGTTTACTACACGATGCTGCTTCCCTCACCTGCAATCATCTTTTCTGCAACTCTTGTATTTTTAAGTCCATGAAATCTGCATCCGCTTGTCCTGTATGCAAAATACCTTTCACTCGTCGAGAGGTTCGCCCTGCTCCTCACATCGACAATTTAGTTGCGATCTACAAAAACATGGAAGCTGCATCTGGAACTAATTTATTCCTCACTCAAAATCCATCTGATACCAAATCACCAGAGGAGGAAAAACAAAGGGAAGGTAATGCTGAGTCTGGTGAAAAAGGAACAAGTCGAACTCAAAAAAATCACATTGAGGAGGAAAAGACCCCAGTGAGAAACAAGTCTAGGAAGAAGCTAAAGCCTGGAAAGAAAAGTCCGGCTGCTAGCCGCGCAAAACCTTCTTTTCCTGCTAAGAAAAGAGTTCAAGTGCCACAAGATATTCTCTCAGAAACCCCACTTAGGGATTTAAAGTCAGGAGGCTCTCTTAGTAGAATTAACAAAGAAGGAACACAAAAGGCTTTCACCAAGGGAAATGCAATGGAAATTCGGAGTGAAAAAGGTGATTGTGTGAAAGAACCATTCTTTTGGTTAAGAGAGGTGCAAGAAGGTGAAATATTAAGTGGGCCCACTGATGAGGATCAAATTATTGAGGGTTCAACGCCGGTTCCTCCTTCATTTAGTGATCTTAAAGATGCTGATGATGAAAGCCCTACAAAACAAGCTCCATCAGATGAGGTGCAAAACAAACCATCTGTTAATTTATTTGATAGTGAGATGTTTGAATGGACACAAAAGCCATGCTCCCCTGAATTATTTTCAACTCCGACCAAAATGCAGGTTGAGGATGCTGTTGATATTGATGAAATTGATGAGGAAATAGTGGCAGCAACTCAAGAGCATCAGTCAAGTGCTGATGCTTACAGTACACAATTTGCAAATCCAAATGGTAATCAATTGGCTAATACATTACCACCAGGTTCCTCTCAGATTAAAAGTTCTGATGATCTAAATGGAAAAAAGAAGTCTACAAAGAGAAGCAGGAAGGCTAGAGAAAAATATAGGCAGGACCATATTAGAGAACTAAATTGCCAAAGTGATGTTATGAATATGGATTCAAATATAACATCAAAAGCCATTGAGGAGCAATCATTGGACCATAAAAGCAAAGCTTTGAACCTGAAAAAGTCTAGTGGAAGGGCCAAAAGGGTGTGTTTTGTTACTAGTGCAGACTCAACATCTCAAAATGCTTGCACAGTCTCTAATATATTAGGAGTTCAAAACAATAATGAAAGAAAGATGGCTAAGAATTCATATGCTTCATCATCTAAACAAGATAATGAGATGCTATGTCCTAAGAAGATTGCTGGAAAAAGTCAGGTGAAAAGATCTGGAAAACAAAGGCTAGATGTTGTGTGTGACCCACCTGAAGATTTAACTTCAATGCAAAACCAATGCAAAGAGCTTGCTGGATCTGCTTCATCTAGTTTAAGTCCACAGACGGATAATAATAACACCACCAATACTAGGAAAAGAAAAAACAGTTTGTCCAAAAAGTCTATGCCCTGCAGTACTGAAAGGAAGAGTACTAAAAAGTCAAAGCCTTCCCCTGAACTTATCTCTAGGGCTAAAGATGATAAAGAAATTAAGCCAGATGATAGCATTAAGGAAGTTACTGATGTCAGCGTACTGAAGGATTCTTTGAAAGAGAAACAATGTCATTCGACAGATCAACCAGTTTTAAGAAAATGTGTCAGCCATGCCAAAGGGTATCAGTGTGCTTTCTGTCTCTCGTCAGAAGAATCAGAGGCTTCTGGTGCAATTGTGCACTATTTTGATGGCAAGCCCGTCACTGCTGATTATGAAGGAGGATCTAAAGTCATACATTGTCACAGGAATTGCACAGAATGGGCCCCAAATGTATATTTTGAAGGTGATAATGCAATAAATCTCGAAGCTGAAGTAAGTAGAAGTCGGCGAATCAAATGCAGTTTTTGTGGACTTAAAGGAGCTGCACTCGGTTGCTATGAGAAAAGTTGTCGCAGGAGCTTTCATGTCACTTGTGCCAAGTGGACTCCTGAATGTCGATGGGATATGGAAAATTTTGTCATGTTATGCCCTCTACATGCTCCCTCCAAGTTACCATATGAAAGTTCAGGATCGCATCACAGGAGCAAAACACTTGCAGCTACCAAAGCTAAAAGCTGTAGCCTCAAACATGACACTACAACCCAGAGTCGGATTTCTCTTGGATCTCACAAGAAAATTGTGCTGTGTTGTTCAGCTCTATCTTTACAGGAGAGGGATGTTGTTTCCGAATTTGAAAAAGTGTCCAAGTTCACTGTTTCTAAAACTTGGGATTCAAGTGTTACCCATGTAATAGCATCAACAGATGAAAATGGCGCATGCAGAAGGACTCTCAAAGTATTGATGGGTATTCTAGAGGGAAAATGGATTCTCAGCATTGAGTGGATCAAAGCTTGCATAAGAGAAGCTGGACCTGTTGATGAGGACCTTTATGAAGTTAATGTCGACATCCATGGAATTAAGGATGGTCCCCATCTTGGCCGACTAAGAGTATTGAACAAGCAACCAAAGCTTTTTGATGGCTACAAGTTCTATTTTGTTGGAGATTTCATCCCATCATACAAAGGCTATCTGCAAGACCTTGTGATTGCTGCTGGAGGGATAATTCTTCATAGAAAACCTGTATCAGATGACCAAAATCCAGTGTCACATATCCGTCCACAGCAAGCCCTCATAATCTACAATCTTGAGGTTTCTGCTAATTGTAATCCGTTGGAAAAGGATGCAATTTTCAGCCAAAGGCGACATGATGCAGAGGTTTTGGCAAGATCTACTGGTTCAGTGGTTGCAAGTAATACATGGATTCTGAACTCCATTGCTGGCTGCAAGCTGCAAAGCCTTGCTTAA | 2979 | 0.4048 | MGDLERMGRELKCPICWSLLHDAASLTCNHLFCNSCIFKSMKSASACPVCKIPFTRREVRPAPHIDNLVAIYKNMEAASGTNLFLTQNPSDTKSPEEEKQREGNAESGEKGTSRTQKNHIEEEKTPVRNKSRKKLKPGKKSPAASRAKPSFPAKKRVQVPQDILSETPLRDLKSGGSLSRINKEGTQKAFTKGNAMEIRSEKGDCVKEPFFWLREVQEGEILSGPTDEDQIIEGSTPVPPSFSDLKDADDESPTKQAPSDEVQNKPSVNLFDSEMFEWTQKPCSPELFSTPTKMQVEDAVDIDEIDEEIVAATQEHQSSADAYSTQFANPNGNQLANTLPPGSSQIKSSDDLNGKKKSTKRSRKAREKYRQDHIRELNCQSDVMNMDSNITSKAIEEQSLDHKSKALNLKKSSGRAKRVCFVTSADSTSQNACTVSNILGVQNNNERKMAKNSYASSSKQDNEMLCPKKIAGKSQVKRSGKQRLDVVCDPPEDLTSMQNQCKELAGSASSSLSPQTDNNNTTNTRKRKNSLSKKSMPCSTERKSTKKSKPSPELISRAKDDKEIKPDDSIKEVTDVSVLKDSLKEKQCHSTDQPVLRKCVSHAKGYQCAFCLSSEESEASGAIVHYFDGKPVTADYEGGSKVIHCHRNCTEWAPNVYFEGDNAINLEAEVSRSRRIKCSFCGLKGAALGCYEKSCRRSFHVTCAKWTPECRWDMENFVMLCPLHAPSKLPYESSGSHHRSKTLAATKAKSCSLKHDTTTQSRISLGSHKKIVLCCSALSLQERDVVSEFEKVSKFTVSKTWDSSVTHVIASTDENGACRRTLKVLMGILEGKWILSIEWIKACIREAGPVDEDLYEVNVDIHGIKDGPHLGRLRVLNKQPKLFDGYKFYFVGDFIPSYKGYLQDLVIAAGGIILHRKPVSDDQNPVSHIRPQQALIIYNLEVSANCNPLEKDAIFSQRRHDAEVLARSTGSVVASNTWILNSIAGCKLQSLA | 992 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vivi1003g00002 | 992 | Gene3D | BRCT domain | 767 | 873 | IPR036420 | - | |
Vivi1003g00002 | 992 | Gene3D | BRCT domain | 879 | 985 | IPR036420 | - | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 314 | 349 | - | - | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 92 | 129 | - | - | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 84 | 195 | - | - | |
Vivi1003g00002 | 992 | Gene3D | Zinc/RING finger domain, C3HC4 (zinc finger) | 602 | 726 | IPR013083 | - | |
Vivi1003g00002 | 992 | ProSitePatterns | Zinc finger RING-type signature. | 28 | 37 | IPR017907 | - | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 222 | 266 | - | - | |
Vivi1003g00002 | 992 | ProSiteProfiles | BRCT domain profile. | 796 | 857 | IPR001357 | - | |
Vivi1003g00002 | 992 | FunFam | Breast cancer associated RING 1 | 1 | 83 | - | - | |
Vivi1003g00002 | 992 | PANTHER | BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN BRCA1 | 2 | 990 | IPR031099 | GO:0006281|GO:0006974 | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 539 | 568 | - | - | |
Vivi1003g00002 | 992 | ProSiteProfiles | Zinc finger RING-type profile. | 13 | 51 | IPR001841 | - | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 314 | 370 | - | - | |
Vivi1003g00002 | 992 | Pfam | PHD-like zinc-binding domain | 646 | 724 | - | - | |
Vivi1003g00002 | 992 | FunFam | Breast cancer associated RING 1 | 602 | 727 | - | - | |
Vivi1003g00002 | 992 | SMART | BRCT_7 | 880 | 986 | IPR001357 | - | |
Vivi1003g00002 | 992 | SMART | BRCT_7 | 764 | 847 | IPR001357 | - | |
Vivi1003g00002 | 992 | SMART | PHD_3 | 677 | 725 | IPR001965 | - | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 471 | 568 | - | - | |
Vivi1003g00002 | 992 | CDD | BRCT_Bard1_rpt1 | 771 | 844 | - | - | |
Vivi1003g00002 | 992 | Pfam | Zinc finger, C3HC4 type (RING finger) | 12 | 50 | - | - | |
Vivi1003g00002 | 992 | ProSiteProfiles | BRCT domain profile. | 878 | 992 | IPR001357 | - | |
Vivi1003g00002 | 992 | Gene3D | Zinc/RING finger domain, C3HC4 (zinc finger) | 2 | 82 | IPR013083 | - | |
Vivi1003g00002 | 992 | MobiDBLite | consensus disorder prediction | 493 | 526 | - | - | |
Vivi1003g00002 | 992 | FunFam | Breast cancer type 1 susceptibility protein homolog | 768 | 874 | - | - | |
Vivi1003g00002 | 992 | SUPERFAMILY | BRCT domain | 882 | 990 | IPR036420 | - | |
Vivi1003g00002 | 992 | SUPERFAMILY | BRCT domain | 771 | 870 | IPR036420 | - | |
Vivi1003g00002 | 992 | ProSiteProfiles | Extended PHD (ePHD) domain profile. | 605 | 725 | IPR034732 | - | |
Vivi1003g00002 | 992 | Pfam | BRCA1 C Terminus (BRCT) domain | 789 | 844 | IPR001357 | - | |
Vivi1003g00002 | 992 | SMART | ring_2 | 678 | 724 | IPR001841 | - | |
Vivi1003g00002 | 992 | SMART | ring_2 | 13 | 50 | IPR001841 | - | |
Vivi1003g00002 | 992 | SUPERFAMILY | RING/U-box | 4 | 73 | - | - |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vivi1003g00002 | 6 | 63 | RAD5 or RAD16-like Gene Family | AT5G22750 | 35.000 | 7.00e-06 | 48.1 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vivi1003g00002 | K10683 | - | gmx:100804958 | 1226.85 |